Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Intermittent preventive treatment of malaria in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) decreases placental parasitaemia, thus improving birth outcomes. Zambian policy recommends monthly SP-IPTp doses given presumptively during pregnancy at each antenatal examination, spaced one month apart after 16 weeks of gestation. The effectiveness of SP-IPTp was evaluated in Zambia where a recent study showed moderate prevalence of Plasmodium falciparum parasites with genetic mutations that confer SP resistance. METHODS: HIV-negative women were enrolled at the time of delivery at two facilities in Mansa, Zambia, an area of high malaria transmission. Women were interviewed and SP exposure was determined by antenatal card documentation or self-reports. Using Poisson regression modelling, the effectiveness of SP-IPTp was evaluated for outcomes of parasitaemia (microscopic examination of maternal peripheral, cord, and placental blood films), maternal anaemia (Hb < 11 g/dl), placental infection (histopathology), and infant outcomes (low birth weight (LBW), preterm delivery, and small for gestational age) in women who took 0-4 doses of SP-IPTp. RESULTS: Participants included 435 women, with a median age of 23 years (range 16-44). Thirty-four women took zero doses of SP-IPTp, while 115, 142 and 144 women took one, two, or ≥ three doses, respectively. Multivariate Poisson regression models considering age, mosquito net usage, indoor residual spraying, urban home, gravidity, facility, wet season delivery, and marital status showed that among paucigravid women ≥ two doses of SP-ITPp compared to one or less doses was associated with a protective effect on LBW (prevalence ratio (PR) 0.33, 95% confidence interval (CI) 0.12-0.91) and any infection (PR 0.76, CI 0.58-0.99). Multivariate models considering SP-IPTp as a continuous variable showed a protective dose-response association with LBW (paucigravid women: PR 0.54, CI 0.33-0.90, multigravid women: PR 0.63, CI 0.41-0.97). CONCLUSIONS: In Mansa, Zambia, an area of moderate SP resistance, ≥ two doses of SP-IPTp were associated with a protective effect from malaria in pregnancy, especially among paucigravid women. Each dose of SP-IPTp contributed to a 46 and 37% decrease in the frequency of LBW among paucigravid and multigravid women, respectively. SP-IPTp remains a viable strategy in this context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432
Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
Peters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007) · Drug Safety · doi:10.2165/00002018-200730060-00003 · Cited by 174
Kayentao, K., Kodio, M., Newman, R. D., Maiga, H., Doumtabe, D., Ongoiba, A., Coulibaly, D., Keita, A. S., Maiga, B., Mungai, M., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/426400 · Cited by 162 · cited 1×
“Earlier studies showed that SP-IPTp decreased placental malaria parasitaemia [9-17], maternal anaemia [11,12,15,18], and LBW [15-17,19].”
BackgroundHarrington, W. E., Mutabingwa, T. K., Kabyemela, E., Fried, M., & Duffy, P. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir376 · Cited by 156 · cited 2×
“Previous studies have examined SP-IPTp outcomes in areas of high prevalence of the quintuple SP mutations [22,38-42], sometimes demonstrating that protective effectiveness is waning or SP-IPTp is harmful [22,43].”
BackgroundFiller, S. J., Kazembe, P., Thigpen, M., Macheso, A., Parise, M. E., Newman, R. D., Steketee, R. W., & Hamel, M. (2006) · The Journal of Infectious Diseases · doi:10.1086/505080 · Cited by 108
Self-citationMaiga, O. M., Kayentao, K., Traore, B. T., Djimde, A., Traore, B., Diallo, M., Ongoiba, A., Doumtabe, D., Doumbo, S., Traore, M. S., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir374 · Cited by 78
Njagi, J. K., Magnussen, P., Estambale, B., Ouma, J., & Mugo, B. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)90141-6 · Cited by 78
Kalilani, L., Mofolo, I., Chaponda, M., Rogerson, S. J., & Meshnick, S. R. (2010) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2010.01.013 · Cited by 74 · cited 1×
“Other studies in sub-Saharan Africa suggest that SP-IPTp effectiveness is weakening [22,23].”
BackgroundChallis, K., Osman, N. B., Cotiro, M., Nordahl, G., Dgedge, M., & Bergström, S. (2004) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01307.x · Cited by 58 · cited 1×
“Earlier studies showed that SP-IPTp decreased placental malaria parasitaemia [9-17], maternal anaemia [11,12,15,18], and LBW [15-17,19].”
Background
Cited by
Fried, M., & Duffy, P. E. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025551 · Cited by 202
Desai, M., Gutman, J., Taylor, S. M., Wiegand, R. E., Khairallah, C., Kayentao, K., Ouma, P., Coulibaly, S. O., Kalilani, L., Mace, K. E., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ881 · Cited by 174
“Methods Study Sites and Study Period The studies were conducted between 2009 and 2013 at 8 sites in 6 countries: 2 countries in West Africa (Mali [2 sites] and Burkina Faso [16]) and 4 in eastern and southern Africa (Zambia [19, 20], Malawi [2 sites] [15, 17, 21], Uganda [14], and Kenya [18]).”
Self-citationMoore, K. A., Simpson, J. A., Scoullar, M. J. L., McGready, R., & Fowkes, F. J. I. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30340-6 · Cited by 165
Metadata
- Authors
- Mace, K. E., Chalwe, V., Katalenich, B. L., Nambozi, M., Mubikayi, L., Mulele, C. K., Wiegand, R. E., Filler, S. J., Kamuliwo, M., Craig, A. S., & Tan, K. R.
- Venue
- Malaria Journal
- Published
- 2015-02-07
- Volume
- 14
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2128102951
- Cited by
- 35
- References
- 11
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. https://app.cochat.ai/papers/10.1186/s12936-015-0576-8
- The paper
- Mace, K. E., Chalwe, V., Katalenich, B. L., Nambozi, M., Mubikayi, L., Mulele, C. K., Wiegand, R. E., Filler, S. J., Kamuliwo, M., Craig, A. S., & Tan, K. R. (2015). Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Malaria Journal. https://doi.org/10.1186/s12936-015-0576-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.